Status of Cytomegalovirus Prevention and Treatment in 2000.

scientific article

Status of Cytomegalovirus Prevention and Treatment in 2000. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11701550

P50authorDon J. DiamondQ37374385
Mark R WillsQ37829205
Simon F LaceyQ56978267
P2093author name stringJ. Sun
Stanley Riddell
C. La Rosa
John A. Zaia
A.J. Carmichael
J.G. Patrick Sissons
M. Gandhi
M. Villacres
M.P. Weekes
S. Markel
P921main subjectCytomegalovirusQ6946
P304page(s)339-355
P577publication date2000-01-01
P1433published inHematology / the Education Program of the American Society of HematologyQ26842068
P1476titleStatus of Cytomegalovirus Prevention and Treatment in 2000.

Reverse relations

cites work (P2860)
Q36824066A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector.
Q33280303CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects
Q34975513Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.
Q78512355Immune pathophysiology of aplastic anemia
Q30484888Introducing mediterranean journal of hematology and infectious diseases
Q36399914Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease